Becton, Dickinson and Co. | BDX - Current Assets

Stock Price
152.13
Daily Change
-2.72 -1.76%
Monthly
-3.88%
Yearly
-25.82%
Q2 Forecast
155.05

Becton, Dickinson and Co. reported $9.19B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
Agilent USD 4.62B 21M Dec/2025
Align Technology USD 2.62B 82.47M Dec/2025
AngioDynamics USD 161.35M 4.69M Sep/2025
Avanos Medical USD 355.4M 4M Dec/2025
Baxter International USD 6.87B 61M Dec/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Bio-Rad Laboratories USD 2.91B 64.2M Dec/2025
Boston Scientific USD 8.79B 759M Dec/2025
Cooper Companies USD 2.13B 27.4M Dec/2025
Danaher USD 13.94B 1.18B Mar/2026
Dentsply International USD 2.02B 49M Dec/2025
Dexcom USD 4.03B 1.19B Dec/2025
Edwards Lifesciences USD 6.74B 380M Dec/2025
Globus Medical USD 2.13B 201.25M Dec/2025
Insulet USD 1.91B 54.6M Dec/2025
Integra LifeSciences USD 1.16B 15.96M Dec/2025
Intuitive Surgical USD 11.52B 881.5M Mar/2026
J&J USD 59.17B 3.55B Mar/2026
Masimo USD 926M 122.3M Dec/2025
Medtronic USD 24.07B 75M Dec/2025
Solventum Corp USD 3.86B 548M Dec/2025
Stryker USD 14.76B 1.04B Dec/2025
Tandem Diabetes Care USD 618.14M 1.2M Dec/2025
Teleflex USD 1.94B 47.65M Dec/2025
Terumo JPY 815.56B 71.48B Dec/2025
Thermo Fisher Scientific USD 22.32B 6.39B Mar/2026
Zimmer Biomet Holdings USD 5.12B 715M Dec/2025